Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.51USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$0.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,706
52-wk High
$2.00
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $19.46
Shares Outstanding(Mil.): 12.97
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.05 -- --
ROI: -82.09 15.07 14.61
ROE: -82.23 16.59 16.33

BRIEF-Arca Biopharma Q1 Loss Per Share $0.20

* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 May 2018

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

23 Apr 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $43.93 -0.13
Novartis AG (NOVN.S) CHF81.80 -0.08
Merck & Co., Inc. (MRK.N) $70.78 -0.32
Roche Holding Ltd. (ROG.S) CHF233.00 -2.15
Roche Holding Ltd. (RO.S) CHF234.00 -1.40
Abbott Laboratories (ABT.N) $71.44 +2.39
Bayer AG (BAYGn.DE) €76.15 -0.37
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.86 -0.64
Eli Lilly And Co (LLY.N) $105.59 -0.74

Earnings vs. Estimates